Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (21-30 of 321) with videos related to

Pageof 33
Sort By:
Nature Reviews. Clinical Oncology|April 16, 2014
Melanoma: MSLT-1--putting sentinel lymph node biopsy into contextVernon K Sondak, Jonathan S Zager
Clinical & Experimental Metastasis|July 25, 2018
Future perspectives: cancer metastasesStanley P Leong, Jonathan S Zager
Journal of Clinical Medicine|June 28, 2023
Isolated Limb Infusion for Limb-Threatening, Unresectable Sarcoma: Past Progress, Current Applications, and Future DirectionsDanielle K DePalo, Jonathan S Zager
Expert Review of Anticancer Therapy|February 23, 2018
Intralesional therapy as a treatment for locoregionally metastatic melanomaJohn T Miura, Jonathan S Zager
Surgical Oncology Clinics of North America|September 14, 2015
Genetic Testing in the Multidisciplinary Management of MelanomaOmar M Rashid, Jonathan S Zager
Clinical & Experimental Metastasis|May 26, 2018
EditorialStanley P Leong, Jonathan S Zager
Expert Opinion on Biological Therapy|November 7, 2019
An evaluation of talimogene laherparepvec for the treatment of melanomaKristy K Broman, Jonathan S Zager
Hematology/Oncology Clinics of North America|November 12, 2025
Management of In-Transit Metastatic MelanomaMatthew C Perez, Jonathan S Zager
Expert Opinion on Drug Metabolism & Toxicology|April 30, 2013
Clinical development of dabrafenib in BRAF mutant melanoma and other malignanciesGeoffrey T Gibney, Jonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|February 9, 2017
Chemosaturation With Percutaneous Hepatic Perfusion in Unresectable Hepatic MetastasesEvan S Glazer, Jonathan S Zager
Pageof 33

Showing results (21-30 of 321) with videos related to

Sort By:
Pageof 33
Nature Reviews. Clinical Oncology|April 16, 2014
Melanoma: MSLT-1--putting sentinel lymph node biopsy into contextVernon K Sondak, Jonathan S Zager
Clinical & Experimental Metastasis|July 25, 2018
Future perspectives: cancer metastasesStanley P Leong, Jonathan S Zager
Journal of Clinical Medicine|June 28, 2023
Isolated Limb Infusion for Limb-Threatening, Unresectable Sarcoma: Past Progress, Current Applications, and Future DirectionsDanielle K DePalo, Jonathan S Zager
Expert Review of Anticancer Therapy|February 23, 2018
Intralesional therapy as a treatment for locoregionally metastatic melanomaJohn T Miura, Jonathan S Zager
Surgical Oncology Clinics of North America|September 14, 2015
Genetic Testing in the Multidisciplinary Management of MelanomaOmar M Rashid, Jonathan S Zager
Clinical & Experimental Metastasis|May 26, 2018
EditorialStanley P Leong, Jonathan S Zager
Expert Opinion on Biological Therapy|November 7, 2019
An evaluation of talimogene laherparepvec for the treatment of melanomaKristy K Broman, Jonathan S Zager
Hematology/Oncology Clinics of North America|November 12, 2025
Management of In-Transit Metastatic MelanomaMatthew C Perez, Jonathan S Zager
Expert Opinion on Drug Metabolism & Toxicology|April 30, 2013
Clinical development of dabrafenib in BRAF mutant melanoma and other malignanciesGeoffrey T Gibney, Jonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|February 9, 2017
Chemosaturation With Percutaneous Hepatic Perfusion in Unresectable Hepatic MetastasesEvan S Glazer, Jonathan S Zager
Pageof 33